Jo‐Anne H. Young

15.7k total citations · 4 hit papers
96 papers, 9.0k citations indexed

About

Jo‐Anne H. Young is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, Jo‐Anne H. Young has authored 96 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Epidemiology, 34 papers in Oncology and 31 papers in Infectious Diseases. Recurrent topics in Jo‐Anne H. Young's work include Hematopoietic Stem Cell Transplantation (27 papers), Cytomegalovirus and herpesvirus research (24 papers) and Neutropenia and Cancer Infections (17 papers). Jo‐Anne H. Young is often cited by papers focused on Hematopoietic Stem Cell Transplantation (27 papers), Cytomegalovirus and herpesvirus research (24 papers) and Neutropenia and Cancer Infections (17 papers). Jo‐Anne H. Young collaborates with scholars based in United States, Canada and France. Jo‐Anne H. Young's co-authors include John R. Wingard, Michael Boeckh, Kent A. Sepkowitz, Alison G. Freifeld, James I. Ito, Eric J. Bow, Issam Raad, Craig A. Mullen, Kenneth V. I. Rolston and George R. Thompson and has published in prestigious journals such as New England Journal of Medicine, Blood and PLoS ONE.

In The Last Decade

Jo‐Anne H. Young

92 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

2011 2.3k citations Eric J. Bow, Michael Boeckh et al. profile →
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

2016 1.8k citations Thomas F. Patterson, George R. Thompson et al. profile →
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

2009 1.1k citations Jan Storek, Jo‐Anne H. Young et al. Biology of Blood and Marrow Transplantation profile →
Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

2011 507 citations Eric J. Bow, Michael Boeckh et al. profile →

Peers

Countries citing papers authored by Jo‐Anne H. Young

Since Specialization

Citations

This map shows the geographic impact of Jo‐Anne H. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo‐Anne H. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo‐Anne H. Young more than expected).

Fields of papers citing papers by Jo‐Anne H. Young

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo‐Anne H. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo‐Anne H. Young. The network helps show where Jo‐Anne H. Young may publish in the future.

Co-authorship network of co-authors of Jo‐Anne H. Young

This figure shows the co-authorship network connecting the top 25 collaborators of Jo‐Anne H. Young. A scholar is included among the top collaborators of Jo‐Anne H. Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo‐Anne H. Young. Jo‐Anne H. Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Letermovir for Prevention of Recurrent Cytomegalovirus in High-Risk Allogeneic Hematopoietic Cell Transplantation Recipients 2024 ·Transplantation and Cellular Therapy ·(unknown), Anat Stern, Yeon Joo Lee, Y. Li, Parastoo B. Dahi, Roni Tamari, Boglarka Gyurkocza, Ann A. Jakubowski, Esperanza B. Papadopoulos, Brian C. Shaffer, Miguel‐Angel Perales, (unknown), Jo‐Anne H. Young, Genovefa A. Papanicolaou	0
2	Daily Fungal Cell-Free DNA Testing to Assess Clinical Status during Candida krusei Fungemia 2024 ·Journal of Fungi ·Jo‐Anne H. Young, (unknown), (unknown), (unknown), Wei Wang, (unknown), Chi Zhang, (unknown)	0
3	Modeling Invasive Aspergillosis Risk for the Application of Prophylaxis Strategies 2024 ·Open Forum Infectious Diseases ·Jo‐Anne H. Young, David R. Andes, Monica I. Ardura, Antonio Arrieta, Eric J. Bow, Pranatharthi Chandrasekar, Sharon C.‐A. Chen, Sarah P. Hammond, Shahid Husain, Sophia Koo, Valéry Lavergne, M. Hong Nguyen, Thomas F. Patterson, Miranda So, George R. Thompson, C. Orla Morrissey, Mindy G. Schuster	12
4	Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients 2024 ·Blood Advances ·Sanjeet Dadwal, Rajat Bansal, Michael W. Schuster, Jean A. Yared, Gary Douglas Myers, Michelle Matzko, Sama Adnan, (unknown), Julie Ma, Sarah A. Gilmore, Spyridoula Vasileiou, Ann M. Leen, Joshua A. Hill, Jo‐Anne H. Young	10
5	A multicenter prospective study to define the natural history of BK viral infections in kidney transplantation 2024 ·Transplant Infectious Disease ·Michael E. Seifert, Roslyn B. Mannon, Anoma Nellore, Jo‐Anne H. Young, Alexander C. Wiseman, David J. Cohen, V. Ram Peddi, Daniel C. Brennan, Charity J. Morgan, Kalyani Peri, Inmaculada Aban, Richard J. Whitley, John W. Gnann	3
6	Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection 2024 ·The Journal of Infectious Diseases ·Sunwen Chou, Drew J. Winston, Robin K. Avery, Catherine Cordonnier, Rafael F. Duarte, Shariq Haider, (unknown), Karl S. Peggs, Carlos Solano, Jo‐Anne H. Young, Joan Gu, (unknown), Genovefa A. Papanicolaou	5
7	A randomized, placebo‐controlled, dose‐escalation phase I/II multicenter trial of low‐dose cidofovir for BK polyomavirus nephropathy 2024 ·Transplant Infectious Disease ·Hannah Imlay, John W. Gnann, (unknown), V. Ram Peddi, Alexander C. Wiseman, Michelle A. Josephson, Clifton E. Kew, Jo‐Anne H. Young, Deborah Adey, Milagros Samaniego, Richard J. Whitley, Ajit P. Limaye	2
8	Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes 2023 ·Blood Advances ·(unknown), Daniel J. Weisdorf, Ryan Shanley, Ahmad Rayes, Shernan G. Holtan, Jo‐Anne H. Young, Margaret L. MacMillan, Najla El Jurdi	5
9	Steroid-Sensitive, but Not Steroid-Dependent or Steroid-Resistant Acute Graft-versus-Host Disease, Results in Similar Infection Risk as No Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation 2022 ·Transplantation and Cellular Therapy ·Jo‐Anne H. Young, Najla El Jurdi, Ahmad Rayes, Margaret L. MacMillan, Shernan G. Holtan, Qing Cao, (unknown), Mukta Arora, Daniel J. Weisdorf	3
10	Aspergillus Infections 2021 ·New England Journal of Medicine ·George R. Thompson, Jo‐Anne H. Young	92
11	Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study 2021 ·Transplant Infectious Disease ·Emily A. Blumberg, Gary Collins, Jo‐Anne H. Young, M. Hong Nguyen, David Michonneau, Zelalem Temesgen, Julia Origüen, Laura Barcán, (unknown), Waldo Belloso, Julien Gras, Giulio Maria Corbelli, James D. Neaton, Jens Lundgren, David R. Snydman, Jean‐Michel Molina, (unknown)	4
12	Detection and treatment of cerebral toxoplasmosis in an aplastic pediatric post-allogeneic hematopoietic cell transplant patient: a case report 2021 ·BMC Infectious Diseases ·(unknown), Margaret L. MacMillan, Mark R. Schleiss, (unknown), Jo‐Anne H. Young, Christen L. Ebens	1
13	Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients 2021 ·Transplant Infectious Disease ·(unknown), (unknown), Qing Cao, (unknown), (unknown), (unknown), Jo‐Anne H. Young, Timothy L. Pruett, Daniel J. Weisdorf, Celalettin Üstün	8
14	Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor- and Steroid-Free Regimen for Pancreas Transplant Recipients 2020 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·Adam Kaplan, Jo‐Anne H. Young, Raja Kandaswamy, Danielle Berglund, Bettina M. Knoll, (unknown), Winston Cavert, Arthur J. Matas, (unknown)	3
15	Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy 2019 ·Biology of Blood and Marrow Transplantation ·Steven A. Pergam, Janet A. Englund, Mini Kamboj, Hayley A. Gans, Jo‐Anne H. Young, Joshua A. Hill, Bipin N. Savani, Roy F. Chemaly, Sanjeet Dadwal, Jan Storek, Jeffery Duchin, Paul A. Carpenter	19
16	Pretransplant Gut Colonization with Intrinsically Vancomycin-Resistant Enterococci (E. gallinarum and E. casseliflavus) and Outcomes of Allogeneic Hematopoietic Cell Transplantation 2018 ·Biology of Blood and Marrow Transplantation ·Armin Rashidi, Maryam Ebadi, Robin Shields‐Cutler, Todd E. DeFor, Gabriel A. Al‐Ghalith, Patricia Ferrieri, Jo‐Anne H. Young, Gary M. Dunny, Dan Knights, Daniel J. Weisdorf	13
17	Alternative donor hematopoietic cell transplantation for Fanconi anemia 2015 ·Blood ·Margaret L. MacMillan, Todd E. DeFor, Jo‐Anne H. Young, Kathryn E. Dusenbery, Bruce R. Blazar, Arne Slungaard, Heather Zierhut, Daniel J. Weisdorf, John E. Wagner	66
18	Time Trends in Fungal Infections as a Cause of Death in Hematopoietic Stem Cell Transplant Recipients 2009 ·American Journal of Clinical Pathology ·Mariam Alsharif, (unknown), Jo‐Anne H. Young, Kay Savik, Jonathan C. Henriksen, H. Evin Gulbahce, Stefan E. Pambuccian	24
19	Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study 2008 ·Blood ·Drew J. Winston, Jo‐Anne H. Young, Vinod Pullarkat, Genovefa A. Papanicolaou, Ravi Vij, Estil Vance, George Alangaden, Roy F. Chemaly, Finn Bo Petersen, Nelson J. Chao, Jared Klein, Kellie Sprague, Stephen Villano, Michael Boeckh	177
20	MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival 2008 ·Cancer Research ·Harry Jin, Renhui Yang, Zhong Zheng, Mally Romero, (unknown), Hani Bou-Reslan, Richard A.D. Carano, Ian Kasman, Elaine Mai, Jo‐Anne H. Young, (unknown), Zemin Zhang, Sarajane Ross, (unknown), (unknown), Mark Merchant	171

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact